Many studies have revealed that transgenic overexpression of α-Klotho not only extends lifespan by 20–30% (11) but also promotes cardiovascular protection, including improvement of endothelial dysfunction, hypotensive effects, alleviating cardiac fibrosis, and arterial stiffening (12–15). This evidence concerns the gene KL and endothelial dysfunction.